PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 5417: Recurrence-free survival in patients with early-stage HPV-associated adenocarcinoma of the cervix stratified by Silva patterns.

View Full Paper
ASAna Lucia Rosario SantosHBHisham F. BahmadJRJovanka Ravix

Key Points

  • This study aims to evaluate the impact of Silva Pattern classification on recurrence-free survival in early-stage HPV-associated adenocarcinoma of the cervix.
  • Retrospective analysis of patients with surgically treated FIGO Stage IA-IB2 HPV-associated adenocarcinoma.
  • Pathology specimens reviewed by gynecologic pathologists to assign Silva patterns.
  • Clinical data obtained from electronic medical records to analyze recurrence-free survival.
  • 42.9% recurrence-free survival in Silva Pattern C compared to 100% in Silva Patterns A/B.
  • Three recurrences occurred exclusively in the Silva Pattern C group.
  • None of the patients with Silva Pattern C who recurred met Sedlis criteria for adjuvant radiation.

Abstract

Abstract Background: HPV-associated adenocarcinoma of the cervix presents challenges in adjuvant treatment compared to squamous cell carcinoma of the cervix. Silva Pattern-based classification has emerged as a histomorphologic predictor supplementing the traditional Sedlis Criteria established in GOG 92. While not part of FIGO staging, it is considered in clinical guidelines, as the Silva Pattern C confers a higher risk of nodal metastasis and disease recurrence; however, its prognostic role in early-stage disease and in patients who do not meet Sedlis criteria remains less defined. We aimed to determine whether Recurrence-free survival (RFS) in patients with early-stage HPV-associated adenocarcinoma of the cervix differs between patients with Silva Pattern C and those with A/B. We hypothesize that Silva Pattern C can guide adjuvant management in patients with negative Sedlis Criteria. Methods: We conducted a retrospective study of patients with surgically treated FIGO Stage IA-IB2 HPV-associated adenocarcinoma of the cervix. Cases were identified through our institutional pathology database under an IRB-approved protocol (2015 to 2025). Pathology specimens from cone biopsies and hysterectomies were reviewed by gynecologic pathologists. Silva patterns were assigned accordingly. Clinical data were obtained from electronic medical records. The study outcome was to determine the RFS, measured from diagnosis to recurrence or to the last follow-up. A Kaplan-Meier analysis was used to compare Silva patterns A/B vs. pattern C. Results: Our sample consisted of 13 patients with HPV-associated adenocarcinoma of the cervix. We identified 6 patients with Silva Patterns A/B and 7 with Silva Pattern C. Three recurrences occurred exclusively in the Silva Pattern C group. RFS was 42.9% in Silva C and 100% in Silva A/B (log-rank p-value: 0.4142). Median follow-up was 29 months (6-108 months) for Silva Pattern C and 15 months (0-46 months) for Silva Pattern A/B. All recurrences occurred in patients with FIGO stage IA2-IB1 disease who did not meet Sedlis Criteria for adjuvant radiation. Times to recurrence were 10, 24, and 90 months. Conclusions: Patients with Silva Pattern C experienced worse RFS. None of the patients with Silva Pattern C who recurred met Sedlis criteria for adjuvant radiation. Sedlis criteria mainly guide squamous cell carcinoma management; only 12% of GOG 92 patients had adenocarcinoma, limiting its use for this group. Our findings suggest that the Silva pattern C may provide clinically actionable prognostic information and can help guide multidisciplinary discussions regarding adjuvant management. Prospective validation of clinical algorithms incorporating Silva pattern-based classification in larger cohorts is warranted. Citation Format: Ana Lucia Rosario Santos, Hisham Bahmad, Jovanka Ravix, Andre Pinto, Navya Nair, . Recurrence-free survival in patients with early-stage HPV-associated adenocarcinoma of the cervix stratified by Silva patterns abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 5417.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Santos et al. (2026) studied this question.

synapsesocial.com/papers/69d1fe07a79560c99a0a480bhttps://doi.org/10.1158/1538-7445.am2026-5417
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Integrating the Silva pattern into clinical practice: a prognostic tool for tailoring surgery and adjuvant therapy in cervical adenocarcinoma2026
  2. 2Abstract 5058: Genomic alterations predictive of outcome in early staged cervical cancer: A translational investigation from the SENTICOL III trial2024
  3. 3#1175 The role of adjuvant radiation in intermediate risk cervical cancer – A population-based cohort study2024
  4. 4Treatment patterns and prognosis of patients with clear cell adenocarcinoma of the cervix: a population-based cohort study2024 · 9 citations
  5. 5587 Effect of substantial lymphovascular space invasion on patterns of first recurrence in FIGO 2009 surgical stage I endometrioid endometrial adenocarcinoma2024 · 2 citations